Pandora Box!

Custom Search

Sunday, October 5, 2008

Are High Doses of Vitamin C Harmful to Our Health?

Vitamin C, in its various forms, is probably the least toxic substance of all supplementary. The US Food and Drug Administration (FDA) evaluated all aspects of metabolisme and potential toxicity of ascorbates before adding them to theis list of "Generally Recognised As Safe" (GRAS) approved substances for oral use.

The only possible negative side-effect of regular large doses of Vitamin C is stomach and abdominal discomfort and diarrhoea. These effects are due to acidic nature of Vitamin C.


What is Win Ester-C250?

Elken's Win Ester-C250 is a unique form of Vitamin C specially produced for its far-reaching nutritional properties.


Patented

Win Ester-C250 was first developed in the early 1970s by an Arizona physician who recognised its importance to our health and well-being. It is a patented and guaranteed product that has maintained its position as the No.1 choice in US for decades.

By composition, Win Ester-C250 is a unique non-acidic combination of mineral ascorbates and all-natural Vitamin C metabolites. The Vitamin C components in Win Ester-C250 transforms in the body to produce Vitamin C metabolites, such as threonate. Whether manufactured in the body or ingested along with supplemental  Vitamin C, the metabolites enhance the concentration of Vitamin C in our cells. Thus, Win Ester-C250 with its added Vitamin C metabolites are more easily absorbed and retained by our body for the benefit of our cells and tissues.


Potency of Win Ester-C250

Every Win Ester-C250 tablet is equivalent to 100mg of ordinary Vitamin C. That means that it is 4 times as effective as 250mg of ordinary Vitamin C. Each tablet also contains 100mg bioflavanoids complex that has a protective effect on the Vitamin C component to facilitate greater absorption.


I will keep on sharing. I hope the informations can help someone who are in need of this type of supplements. For more info, please feel free to contact me. Thank you..


Regards,



Timben

No comments: